These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 12088679)
1. Control of Mycobacterium tuberculosis through mammalian Toll-like receptors. Stenger S; Modlin RL Curr Opin Immunol; 2002 Aug; 14(4):452-7. PubMed ID: 12088679 [TBL] [Abstract][Full Text] [Related]
2. Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. Reiling N; Hölscher C; Fehrenbach A; Kröger S; Kirschning CJ; Goyert S; Ehlers S J Immunol; 2002 Oct; 169(7):3480-4. PubMed ID: 12244136 [TBL] [Abstract][Full Text] [Related]
3. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
4. The role of Toll-like receptors in combating mycobacteria. Krutzik SR; Modlin RL Semin Immunol; 2004 Feb; 16(1):35-41. PubMed ID: 14751762 [TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. Noss EH; Pai RK; Sellati TJ; Radolf JD; Belisle J; Golenbock DT; Boom WH; Harding CV J Immunol; 2001 Jul; 167(2):910-8. PubMed ID: 11441098 [TBL] [Abstract][Full Text] [Related]
6. The role of Toll-like receptors in immunity against mycobacterial infection. Heldwein KA; Fenton MJ Microbes Infect; 2002 Jul; 4(9):937-44. PubMed ID: 12106786 [TBL] [Abstract][Full Text] [Related]
7. Kim WS; Jung ID; Kim JS; Kim HM; Kwon KW; Park YM; Shin SJ Front Cell Infect Microbiol; 2018; 8():95. PubMed ID: 29637049 [No Abstract] [Full Text] [Related]
8. Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals. Feng CG; Scanga CA; Collazo-Custodio CM; Cheever AW; Hieny S; Caspar P; Sher A J Immunol; 2003 Nov; 171(9):4758-64. PubMed ID: 14568952 [TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor signaling in anti-cancer immunity. Okamoto M; Sato M J Med Invest; 2003 Feb; 50(1-2):9-24. PubMed ID: 12630564 [TBL] [Abstract][Full Text] [Related]
10. Toll-like receptors control activation of adaptive immune responses. Schnare M; Barton GM; Holt AC; Takeda K; Akira S; Medzhitov R Nat Immunol; 2001 Oct; 2(10):947-50. PubMed ID: 11547333 [TBL] [Abstract][Full Text] [Related]
11. The role of Toll-like receptors in host defense against microbial infection. Krutzik SR; Sieling PA; Modlin RL Curr Opin Immunol; 2001 Feb; 13(1):104-8. PubMed ID: 11154925 [TBL] [Abstract][Full Text] [Related]
12. [Induction of direct antimicrobial activity through mammalian toll-like receptors]. Stenger S; Engele M; Bölcskei PL; Röllinghoff M; Wagner M Pneumologie; 2002 Feb; 56(2):103-7. PubMed ID: 11842348 [TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor signaling and regulation of cytokine gene expression in the immune system. Ozato K; Tsujimura H; Tamura T Biotechniques; 2002 Oct; Suppl():66-8, 70, 72 passim. PubMed ID: 12395929 [TBL] [Abstract][Full Text] [Related]
14. Stüve P; Minarrieta L; Erdmann H; Arnold-Schrauf C; Swallow M; Guderian M; Krull F; Hölscher A; Ghorbani P; Behrends J; Abraham WR; Hölscher C; Sparwasser TD; Berod L Front Immunol; 2018; 9():495. PubMed ID: 29675017 [No Abstract] [Full Text] [Related]
16. Microbial recognition via Toll-like receptor-dependent and -independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggering. Edwards AD; Manickasingham SP; Spörri R; Diebold SS; Schulz O; Sher A; Kaisho T; Akira S; Reis e Sousa C J Immunol; 2002 Oct; 169(7):3652-60. PubMed ID: 12244157 [TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. Abel B; Thieblemont N; Quesniaux VJ; Brown N; Mpagi J; Miyake K; Bihl F; Ryffel B J Immunol; 2002 Sep; 169(6):3155-62. PubMed ID: 12218133 [TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor pathways in the immune responses to mycobacteria. Quesniaux V; Fremond C; Jacobs M; Parida S; Nicolle D; Yeremeev V; Bihl F; Erard F; Botha T; Drennan M; Soler MN; Le Bert M; Schnyder B; Ryffel B Microbes Infect; 2004 Aug; 6(10):946-59. PubMed ID: 15310472 [TBL] [Abstract][Full Text] [Related]
19. Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide. Tobian AA; Potter NS; Ramachandra L; Pai RK; Convery M; Boom WH; Harding CV J Immunol; 2003 Aug; 171(3):1413-22. PubMed ID: 12874233 [TBL] [Abstract][Full Text] [Related]
20. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. Bulut Y; Faure E; Thomas L; Equils O; Arditi M J Immunol; 2001 Jul; 167(2):987-94. PubMed ID: 11441107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]